Gilead Sciences is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California.
Gilead’s facility in Edmonton, located in the Canadian province of Alberta, is responsible for the development and manufacturing of investigational drugs, as well as supply of active pharmaceutical ingredients for clinical research programs and to support new product launch supplies.
Gilead’s Alberta facility is committed to the development and manufacture of innovative therapeutics in the areas of unmet medical need without adversely affecting the health and safety of our employees, our neighbors, or our environment. For more information about Gilead Alberta’s Environmental Policy, click here.
Gilead Alberta ULC
1021 Hayter Road
Phone: +1 780-701-6400 +1 780-701-6400
Fax: +1 780-472-8189
Gilead’s office in Mississauga, located in the Canadian province of Ontario, provides administrative, commercial, medical, regulatory, public affairs, finance, legal, quality assurance and pharmacovigilance support for Atripla®, Biktarvy®, Cayston®, Complera®, Descovy®, Epclusa™, Genvoya®, Harvoni®, Hepsera®, Odefsey®, Sovaldi®, Stribild®, Truvada®, Vemlidy®, Veklury®, Viread®, Vosevi®, and Zydelig® in Canada.
Gilead Sciences Canada, Inc.
6711 Mississauga Road
Phone: +1 905-363-8008 +1 905-363-8008
Fax: +1 905-363-8019
Canada Medical Information
Phone: 1-905-363-8009 or 1-866-207-4267
This page is intended for visitors outside of the United States.